5Horiguchi T, Kondo R, Miyazaki J, et al. Clinical evaluation of a t- ransdermal therapeutic system of the bela2-agonist tulubuterol in pa- tients with mild or moderate persistent bronchial asthma[ J ]. Arzne- imittelforschung,2004 ,.54( 5 ) :280 - 285.
6Aydogan M, Eifan AO, Keles S, etal. Sublingual immunother- apy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: A double-blind-placebo-controlled random- ised trial[J]. RespiratoryMedieine, 2013, 107(9): 1322-1329.
7Murakami K, Habukawa C, Kurosawa H, etal. Evaluation of airway responsiveness using colored three-dimensional analyses of a new forced oscillation technique in controlled asthmatic and nonasthmatic children [J]. Respiratory Investigation, 2014, 52 (1): 57-64.
8Kotani H, Kishi R, Mouri A, et al. Influence of leukotriene pathway polymorphisms on clinical responses to montelukast in Japanese patients with asthma[ J]. J Clin Pharm Ther,2012,37 ( 1 ) : 112-116.
9Nagata Makoto, Saito Keiko, Tsuchiya Koji, et al. Leukotriene D4 upregulates eosinophil adhesion via the cysteinyl leukotriene 1 receptor [ J ]. J Allergy Clin Immuno1,2002,109 ( 4 ) :676-680.
10Croisant S.Epidemiology of asthma:prevalence and burden of disease[J].Adv Exp Med Biol,2014(795):17-29.
